Main business composition table of A-share listed companies
Field display
| Main business composition table of A-share listed companies |
|---|
| Stock code |
| Report Date |
| Report name |
| Category |
| Product name |
| Product revenue |
| Income proportion |
| Gross profit margin |
| Currency code |
Sample data
| Stock code | Report Date | Report Name | Category | Product name | Product Revenue | Revenue share | Gross profit margin | Currency code |
|---|---|---|---|---|---|---|---|---|
| 600062 | 2021/12/30 | 2021 Annual Report | 2 | Other business | 77880085.16 | 0.0085 | 0.401505538 | Renminbi |
| 600062 | 2021/12/30 | 2021 Annual Report | 3 | Central China and East China | 4243346292 | 0.4657 | 0.633039259 | Renminbi |
| 600062 | 2021/12/30 | 2021 Annual Report | 3 | North China | 1933752503 | 0.2122 | 0.496964849 | Renminbi |
| 600062 | 2021/12/30 | 2021 Annual Report | 3 | South China and Southwest China | 1336424027 | 0.1467 | 0.613290483 | Renminbi |
| 600062 | 2021/12/30 | 2021 Annual Report | 3 | Other regions | 612352062.3 | 0.0672 | 0.181447409 | Renminbi |
| 600062 | 2021/12/30 | 2021 Annual Report | 3 | Northwestern Territory | 536168251.7 | 0.0588 | 0.460085573 | Renminbi |
| 600062 | 2021/12/30 | 2021 Annual Report | 3 | Northeast Region | 371593709.1 | 0.0408 | 0.607259941 | Renminbi |
| 600062 | 2021/12/30 | 2021 Annual Report | 3 | Other business | 77880085.16 | 0.0086 | 0.401505538 | Renminbi |
| 600062 | 2021/9/29 | 2021 Third Quarterly Report | 1 | Non-infusion | 4790194383 | 0.6967 | 0.597787709 | Renminbi |
| 600062 | 2021/9/29 | 2021 Third Quarterly Report | 1 | Infusion | 2029380092 | 0.2952 | 0.536030047 | Renminbi |
| 600062 | 2021/9/29 | 2021 Third Quarterly Report | 1 | Other business | 55728408.98 | 0.0081 | 0.384180247 | Renminbi |
| 600062 | 2021/9/29 | 2021 Third Quarterly Report | 2 | Chronic disease platform | 2279885464 | 0.3316 | 0.794543258 | Renminbi |
| 600062 | 2021/9/29 | 2021 Third Quarterly Report | 2 | Infusion platform | 2029380092 | 0.2952 | 0.536030047 | Renminbi |
| 600062 | 2021/9/29 | 2021 Third Quarterly Report | 2 | Others | 1536789139 | 0.2235 | 0.210035488 | Renminbi |
| 600062 | 2021/9/29 | 2021 Third Quarterly Report | 2 | Specialist platform | 973519779.7 | 0.1416 | 0.74910799 | Renminbi |
| 600062 | 2021/9/29 | 2021 Third Quarterly Report | 2 | Other business | 55728408.98 | 0.0081 | 0.384180247 | Renminbi |
| 600062 | 2021/6/29 | 2021 Interim Report | 1 | Non-infusion | 3255435850 | 0.7031 | 0.60005585 | Renminbi |
| 600062 | 2021/6/29 | 2021 Interim Report | 1 | Infusion | 1340953648 | 0.2896 | 0.538166566 | Renminbi |
| 600062 | 2021/6/29 | 2021 Interim Report | 1 | Other business | 33599464.86 | 0.0073 | 0.495573838 | Renminbi |
| 600062 | 2021/6/29 | 2021 Interim Report | 2 | Chronic disease platform | 1550278374 | 0.3348 | 0.794602988 | Renminbi |
| 600062 | 2021/6/29 | 2021 Interim Report | 2 | Infusion platform | 1340953648 | 0.2896 | 0.538166566 | Renminbi |
| 600062 | 2021/6/29 | 2021 Interim Report | 2 | Others | 1052001142 | 0.2272 | 0.216813105 | Renminbi |
| 600062 | 2021/6/29 | 2021 Interim Report | 2 | Specialist platform | 653156334.7 | 0.1411 | 0.755561628 | Renminbi |
| 600062 | 2021/6/29 | 2021 Interim Report | 2 | Other business | 33599464.86 | 0.0073 | 0.495573838 | Renminbi |
| 600062 | 2021/3/30 | 2021 first quarter report | 1 | Non-infusion | 1732678292 | 0.7272 | 0.627821946 | Renminbi |
| 600062 | 2021/3/30 | 2021 first quarter report | 1 | Infusion | 650053918.8 | 0.2728 | 0.506257418 | Renminbi |
| 600062 | 2021/3/30 | 2021 first quarter report | 2 | Chronic disease platform | 855887811.4 | 0.3592 | 0.804724624 | Renminbi |
| 600062 | 2021/3/30 | 2021 first quarter report | 2 | Infusion platform | 650053918.8 | 0.2728 | 0.506257418 | Renminbi |
| 600062 | 2021/3/30 | 2021 first quarter report | 2 | Other | 537776160.3 | 0.2257 | 0.25366611 | Renminbi |
| 600062 | 2021/3/30 | 2021 first quarter report | 2 | Specialist platform | 339014319.9 | 0.1423 | 0.77472796 | Renminbi |
| 600062 | 2020/12/30 | 2020 Annual Report | 1 | Non-infusion products | 5909454880 | 0.6949 | 0.695430303 | Renminbi |
| 600062 | 2020/12/30 | 2020 Annual Report | 1 | Infusion products | 2481789810 | 0.2918 | 0.493733898 | Renminbi |
| 600062 | 2020/12/30 | 2020 Annual Report | 1 | Other business | 112693540.2 | 0.0133 | 0.211093678 | Renminbi |
| 600062 | 2020/12/30 | 2020 Annual Report | 2 | Chronic disease business platform | 3442094705 | 0.4048 | 0.825177019 | Renminbi |
| 600062 | 2020/12/30 | 2020 Annual Report | 2 | Infusion business platform | 2481789810 | 0.2918 | 0.493733898 | Renminbi |
| 600062 | 2020/12/30 | 2020 Annual Report | 2 | Specialty Business Platform | 1249751438 | 0.147 | 0.746334859 | Renminbi |
| 600062 | 2020/12/30 | 2020 Annual Report | 2 | Other | 1217608736 | 0.1432 | 0.276397069 | Renminbi |
| 600062 | 2020/12/30 | 2020 Annual Report | 2 | Other business | 112693540.2 | 0.0132 | 0.211093678 | Renminbi |
| 600062 | 2020/12/30 | 2020 Annual Report | 3 | Central China and East China | 4721285955 | 0.5552 | 0.711723815 | Renminbi |
| 600062 | 2020/12/30 | 2020 Annual Report | 3 | North China | 1612633383 | 0.1896 | 0.409359941 | Renminbi |
Data update frequency
Annual Update